Intraductal Radiofrequency Thermoablation and Radiotherapy combined treatment for Extrahepatic Cholangiocarcinoma: A Prospective, Single-arm, Multicenter Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008716

Enrollment

Registered

2023-08-18

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : ? Study flow The clinical study will be conducted in the following order. Of patients with extrahepatic cholangiocarcinoma requiring biliary drainage, those who meet the inclusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent. 2.Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma

Exclusion criteria

Exclusion criteria: 1.Patients who refuse to sign the informed consent 2.Patients with metastatic cancer (stage IV) or malignant ascites 3.Patients with intrahepatic cholangiocarcinoma 4.Patients who are unable to undergo endoscopic procedures as determined by the investigator. 5.Patients with a life expectancy of 3 months or less 6.Patients with ID-RFA contraindications: pacemaker, pregnancy, uncorrected bleeding tendency (PT INR > 1.5, platelets < 50,000/mm3)

Design outcomes

Primary

Measure	Time frame
2-year local control rate	—

Secondary

Measure	Time frame
1-year local control rate;Overall survival;Progression-free survival;Local progression-free survival;Period of Stent patency	—

Countries

Korea, Republic of

Contacts

Public ContactYOUNGHWA KANG

National Cancer Center

73324@ncc.re.kr+82-31-920-0743

Outcome results